Skip to main content
Equibles

BNP PARIBAS ARBITRAGE, SA

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 1166588 NEW YORK, NY
Back to ZNTL Full portfolio

Position in ZNTL

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$60,523
-$1,042,641 QoQ
Shares Held
12,479
-97.4% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 114 holders
Holding Since
Sep 2022
8 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. ZNTL ranks #259 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 4,377,120 $306,529,713
2 REGN
Regeneron Pharmaceuticals, Inc.
 399,847 $249,320,598
3 ARGX
Argenx SE
 157,958 $146,548,693
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 262,258 $130,271,416
5 BNTX
BioNTech SE
 1,319,517 $122,781,056
6 RVMD
Revolution Medicines, Inc.
 552,710 $103,511,528
7 ORKA
Oruka Therapeutics, Inc.
 1,079,015 $102,689,857
8 BBIO
BridgeBio Pharma, Inc.
 1,155,442 $86,057,320

All Filings in ZNTL

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $60,523 12,479
2026-03-31 $1,103,164 471,438
2025-12-31 $566,145 419,367
2025-09-30 $239,991 158,935
2025-06-30 $201,241 173,484
2025-03-31 $112,608 70,823
2024-12-31 $534,164 176,292
2022-09-30 $1,658,376 76,564